Latest Posts
About This Stock
More About This Stock
Read
Read
Global Blood Therapeutics Prices A $150.0 Million Common Stock Public Offering
Article By:
NASDAQ GlobeNewswire
Friday, December 7, 2018 10:25 AM EDT
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $150.0 million.
In this article: GBT
Global Blood Therapeutics Announces Full Exercise Of Underwriter’s Option To Purchase Additional Shares
Article By:
NASDAQ GlobeNewswire
Monday, March 12, 2018 12:45 PM EDT
Global Blood Therapeutics, Inc. today announced that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 600,000 shares of GBT’s common stock.
In this article: GBT